Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/n505-1h50

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
technical paper

Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study

ENDO 2021

21 March 2021

Similar lecture

Meet the Scientist: Drugs, Steroids, and Cancer: Bridging the Worlds of Endocrinology, Metabolism, and Oncology
technical paper

Meet the Scientist: Drugs, Steroids, and Cancer: Bridging the Worlds of Endocrinology, Metabolism, and Oncology

ENDO 2021

21 March 2021

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved